EUVIMEDEUVIMED entdecken
Crossref

Investigating the Potential of Selective COX-2 Inhibitors as Multi-Targeted Agents Against KRAS Signaling

Dilan Konyar, Hayati Okur

Journal of the Turkish Chemical Society Section A: Chemistry · 25.07.2026 · 2026 (2) · 1-9

DOI: 10.18596/jotcsa.1887482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Turkish Chemical Society Section A: Chemistry, online erschienen am 25.07.2026. Verfasst von Dilan Konyar und 1 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncogenic RAS (rat sarcoma virus) mutations cause approximately 30% of human malignancies and initiate tumorigenesis through an autocrine feedback mechanism involving the COX-2/PGE2 (cyclooxygenase-2/prostaglandin E2) pathway. This study aims to assess the direct binding affinities and molecular interaction mechanisms of 17 distinct selective and semi-selective COX-2 inhibitors (Parecoxib, Cimicoxib, Celecoxib, Polmacoxib, Mavacoxib, Rofecoxib, etc.) with oncogenic KRAS. Molecular docking simulations were performed using the MOE 2020 (Molecular Operating Environment) program. The wild-type KRAS structure (PDB ID: 4OBE) (protein data bank), obtained by X-ray crystallography, was selected as the target protein. The docking scores (S), RMSD (root-mean-square deviation) values, and binding energies of the medicines were evaluated compared to the reference ligands guanosine diphosphate (GDP) (-6.73 kcal/mol) and guanosine triphosphate (GTP) (-6.87 kcal/mol).The docking data indicate that Parecoxib (-5.91 kcal/mol), Cimicoxib (-5.89 kcal/mol), and Celecoxib (-5.88 kcal/mol) demonstrate the highest binding affinity for KRAS oncoproteins. In line with findings from our previous study, the presence of sulfonamide/sulfonyl groups in the molecular structure and the interaction of aromatic rings with Switch I/II pockets were recognized as crucial factors for increased affinity. Additionally, Polmacoxib (-5.44 kcal/mol), which interacts with carbonic anhydrase (CA), has the potential to reduce systemic toxicity and inhibit oncogenic signaling within a more favorable therapeutic window due to its tissue-specific retention properties. Thus, these drugs exhibiting increased docking scores have been validated as potential candidates for multi-targeted anticancer approaches that target mutations considered “drug-untargetable” by affecting RAS signaling networks.

Zitieren

APA

Konyar, D., & Okur, H. (2026). Investigating the Potential of Selective COX-2 Inhibitors as Multi-Targeted Agents Against KRAS Signaling. Journal of the Turkish Chemical Society Section A: Chemistry, 2026(2), 1-9. https://doi.org/10.18596/jotcsa.1887482

Vancouver

Konyar D, Okur H. Investigating the Potential of Selective COX-2 Inhibitors as Multi-Targeted Agents Against KRAS Signaling. Journal of the Turkish Chemical Society Section A: Chemistry. 2026;2026(2):1-9. doi:10.18596/jotcsa.1887482

BibTeX
@article{Konyar2026,
  author = {Konyar, Dilan and Okur, Hayati},
  title = {Investigating the Potential of Selective COX-2 Inhibitors as Multi-Targeted Agents Against KRAS Signaling},
  journal = {Journal of the Turkish Chemical Society Section A: Chemistry},
  year = {2026},
  volume = {2026},
  number = {2},
  pages = {1--9},
  doi = {10.18596/jotcsa.1887482}
}
Kostenlos starten →